Lilly asks U.S. Supreme Court to rule part of False Claims Act unconstitutional
The Indianapolis-based drugmaker is challenging a $183.7 million judgment in a case brought by a pharmacist who alleged Lilly made false claims about rebates to the federal Medicaid program.